Alexion Pharmaceuticals Buys Synageva For $8.4B; One Stock Falls, The Other Soars

Shares of Alexion fell 13.5% for the day after acquiring Synageva for a 140% premium.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.